Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-20-000042
Filing Date
2020-08-06
Accepted
2020-08-06 17:19:21
Documents
111
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhc-20200630.htm   iXBRL 10-Q 4268651
2 BHC Q2 2020 EX-31.1 exhibit311q22020.htm EX-31.1 12145
3 BHC Q2 2020 EX-31.2 exhibit312q22020.htm EX-31.2 12180
4 BHC Q2 2020 EX-32.1 exhibit321q22020.htm EX-32.1 8531
5 BHC Q2 2020 EX-32.2 exhibit322q22020.htm EX-32.2 8545
  Complete submission text file 0000885590-20-000042.txt   16063512

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20200630.xsd EX-101.SCH 84471
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20200630_cal.xml EX-101.CAL 132131
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20200630_def.xml EX-101.DEF 492378
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20200630_lab.xml EX-101.LAB 918809
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20200630_pre.xml EX-101.PRE 665012
11 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20200630_htm.xml XML 3448289
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 201082809
SIC: 2834 Pharmaceutical Preparations